PerkinElmer, Inc. News Releases http://ir.perkinelmer.com/ PerkinElmer, Inc. News Releases en PerkinElmer to Present at Goldman Sachs Global Healthcare Conference http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-present-goldman-sachs-global-healthcare-conference-4 WALTHAM, Mass. --(BUSINESS WIRE)--May 29, 2019-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Goldman Sachs 40 th Annual Global Healthcare Conference on Wednesday, June 12, 2019 , at 2:40 p.m. Wed, 29 May 2019 16:15:00 -0400 PerkinElmer, Inc. News Releases 21911 PerkinElmer Expands Food Testing Offerings with New Meat & Olive NIR Analyzer http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-expands-food-testing-offerings-new-meat-olive-nir DA 6200™ provides processors of meat and olives improved quality and process control   WALTHAM, Massachusetts – May 6, 2019 – PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that it has launched the DA 6200™ NIR analyzer, which will help meat and Mon, 06 May 2019 09:00:00 -0400 PerkinElmer, Inc. News Releases 21886 PerkinElmer Opens New Facility in Singapore http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-opens-new-facility-singapore Underscores Commitment to Growth in Singapore with Office in JTC MedTech Hub   WHAT:  PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced the opening of a new office facility in Singapore. WHEN & WHERE:  PerkinElmer held a ribbon cutting ceremony to Thu, 02 May 2019 12:00:00 -0400 PerkinElmer, Inc. News Releases 21871 PerkinElmer Announces Financial Results for the First Quarter of 2019 http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-announces-financial-results-first-quarter-2019 Revenue of $648.7 million ; 1% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.32 ; Adjusted EPS of $0.69 Acquisition of Cisbio Bioassays, a leading custom assay service provider, bolsters position in life sciences and diagnostics markets FY19 GAAP earnings per share Thu, 25 Apr 2019 16:15:00 -0400 PerkinElmer, Inc. News Releases 21806 PerkinElmer Board Declares Quarterly Dividend http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-board-declares-quarterly-dividend-42 WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 25, 2019-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on April 25, 2019 . This dividend is payable on August 9, 2019 to all shareholders of record at the close of business Thu, 25 Apr 2019 16:05:00 -0400 PerkinElmer, Inc. News Releases 21801 PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-joins-accentures-life-sciences-ecosystem-help-drive Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier   WALTHAM, Massachusetts – April 16, 2019 – PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today Tue, 16 Apr 2019 09:00:00 -0400 PerkinElmer, Inc. News Releases 21781 PerkinElmer to Hold Earnings Call on Thursday, April 25, 2019 http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-hold-earnings-call-thursday-april-25-2019 WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 11, 2019-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Thursday, April 25, 2019 , after market close, the Company will release first quarter 2019 results. Thu, 11 Apr 2019 16:15:00 -0400 PerkinElmer, Inc. News Releases 21761 PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-genomics-introduces-physician-ordered-genetic Available in Helix’s DNA marketplace, GenePrism: Actionable Insights is the first clinical-grade DNA test available to health individuals that analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics   WALTHAM, Massachusetts – April 2, 2019 – Tue, 02 Apr 2019 10:00:00 -0400 PerkinElmer, Inc. News Releases 21736 PerkinElmer Highlights Analysis and Discovery Innovations Helping to Advance Science and Healthcare at FORUM LABO PARIS 2019 http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-highlights-analysis-and-discovery-innovations WHAT: PerkinElmer -- a global leader committed to innovating for a healthier world – will be at FORUM LABO PARIS 2019, sharing how its advanced detection instruments, software and services help researchers and scientists find answers and breakthroughs more efficiently and effectively.   Mon, 25 Mar 2019 09:00:00 -0400 PerkinElmer, Inc. News Releases 21756 PerkinElmer Receives FDA Clearance for EUROIMMUN Anti-Tissue Transglutaminase ELISA http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-receives-fda-clearance-euroimmun-anti-tissue Serological testing plays critical role in helping diagnose patients with celiac disease WHAT:   PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Wed, 20 Mar 2019 09:00:00 -0400 PerkinElmer, Inc. News Releases 21716